Last reviewed: May 31, 2026 Last updated: May 31, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
An exception existed during the period when semaglutide appeared on the FDA drug shortage list
Several groups 14,16,17,18 have developed elegant microfluidic platforms where individual B-cells can be isolated into nanoliter-sized droplets and individually manipulated to splice cognate V genes and create natively paired scFv libraries for panning via display-based selections or screening by NGS
Association of Multiple Blood Metals with thyroid function in general adults: a Cross-sectional study
The 7 Most Common BPC-157 Mistakes (and How to Avoid Them) Buying from unverified "research" vendors